Concord Biotech Limited

About

Concord Biotech Limited, a, biopharma company, engages in the research and development, manufacture, and sale of pharmaceutical products in India and internationally. It operates through Active Pharmaceutical Ingredients (APIs) and Formulations segments. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsirolimus, everolimus, romidepsin, doxorubicin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment. In addition, the company provides mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, daptomycin, fusidic acid, colistimethate sodium, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi acetate, micafungin sodium, and nystatin for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. Further, the company provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.

Key Metrics

as of Sep 2026

Market Cap14,825 Cr

P/E53.40

Div Yield0.53 %

Book Value₹193.00

52w High₹1,704.00

52w Low₹987.00

Face Value₹1.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	261.00	326.00	278.00	247.00	204.00	430.00	244.00	310.00	216.00	319.00	241.00	262.00	195.00
Expenses	173.00	204.00	176.00	157.00	143.00	239.00	146.00	174.00	135.00	185.00	135.00	143.00	123.00
Operating Profit	87.00	122.00	102.00	91.00	61.00	190.00	98.00	137.00	81.00	134.00	106.00	119.00	72.00
OPM %	33.00	38.00	37.00	37.00	30.00	44.00	40.00	44.00	38.00	42.00	44.00	45.00	37.00
Other Income	13.00	16.00	7.00	13.00	14.00	9.00	15.00	10.00	10.00	11.00	8.00	8.00	7.00
Depreciation	18.00	19.00	19.00	18.00	18.00	15.00	13.00	13.00	13.00	14.00	14.00	13.00	13.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.00	1.00
Profit before tax	82.00	118.00	90.00	86.00	57.00	185.00	99.00	133.00	78.00	131.00	100.00	113.00	65.00
Tax %	26.00	24.00	25.00	26.00	26.00	23.00	25.00	26.00	25.00	26.00	26.00	25.00	25.00
Net Profit	61.00	90.00	68.00	63.00	43.00	142.00	74.00	99.00	58.00	97.00	75.00	84.00	48.00
EPS in Rs	5.85	8.60	6.48	6.01	4.07	13.57	7.08	9.43	5.57	9.29	7.13	8.08	4.63

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2016	Mar 2015
Sales	1,055.00	1,200.00	1,017.00	853.00	713.00	617.00	512.00	436.00	340.00	276.00	239.00
Expenses	678.00	693.00	585.00	509.00	439.00	289.00	308.00	256.00	212.00	145.00	133.00
Operating Profit	377.00	507.00	432.00	344.00	274.00	328.00	205.00	180.00	127.00	131.00	105.00
OPM %	36.00	42.00	42.00	40.00	38.00	53.00	40.00	41.00	37.00	48.00	44.00
Other Income	49.00	44.00	34.00	35.00	23.00	14.00	31.00	17.00	36.00	8.00	11.00
Interest	1.00	1.00	3.00	5.00	6.00	1.00	1.00	1.00	1.00	0.00	1.00
Depreciation	74.00	54.00	54.00	54.00	50.00	28.00	21.00	19.00	18.00	10.00	10.00
Profit before tax	351.00	496.00	409.00	320.00	241.00	313.00	213.00	178.00	144.00	129.00	106.00
Tax %	25.00	25.00	26.00	26.00	26.00	25.00	21.00	33.00	30.00	33.00	34.00
Net Profit	263.00	373.00	305.00	238.00	179.00	235.00	169.00	118.00	100.00	87.00	70.00
EPS in Rs	25.17	35.65	29.13	22.76	187.76	247.44	177.65	124.48	105.66	94.78	76.32
Dividend Payout %	30.00	25.00	30.00	30.00	3.00	0.00	22.00	21.00	0.00	25.00	22.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2016	Mar 2015
Equity Capital	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	9.00	9.00
Reserves	2,009.00	1,802.00	1,515.00	1,282.00	1,098.00	990.00	761.00	673.00	585.00	329.00	268.00
Borrowings	1.00	3.00	10.00	32.00	62.00	89.00	52.00	9.00	22.00	36.00	35.00
Other Liabilities	216.00	219.00	164.00	191.00	144.00	94.00	118.00	71.00	69.00	74.00	55.00
Total Liabilities	2,237.00	2,034.00	1,699.00	1,515.00	1,313.00	1,183.00	941.00	763.00	685.00	448.00	367.00
Fixed Assets	786.00	795.00	575.00	593.00	573.00	546.00	240.00	230.00	189.00	110.00	104.00
CWIP	79.00	51.00	211.00	173.00	74.00	18.00	141.00	19.00	3.00	70.00	19.00
Investments	488.00	335.00	244.00	138.00	74.00	142.00	199.00	229.00	151.00	43.00	42.00
Other Assets	883.00	854.00	668.00	611.00	592.00	477.00	361.00	285.00	343.00	225.00	202.00
Total Assets	2,237.00	2,034.00	1,699.00	1,515.00	1,313.00	1,183.00	941.00	763.00	685.00	448.00	367.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2018
Cash from Operating Activity	264.00	245.00	265.00	246.00	207.00	167.00	155.00	79.00
Cash from Investing Activity	-142.00	-160.00	-155.00	-158.00	-112.00	-195.00	-114.00	-42.00
Cash from Financing Activity	-115.00	-99.00	-99.00	-85.00	-100.00	31.00	-43.00	-37.00
Net Cash Flow	7.00	-14.00	12.00	3.00	-4.00	3.00	-1.00	0.00
Free Cash Flow	169.00	134.00	180.00	101.00	52.00	-37.00	-1.00	79.00
CFO/OP %	96.00	70.00	85.00	92.00	98.00	74.00	100.00	101.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2016	Mar 2015
Debtor Days	159.00	159.00	125.00	117.00	119.00	105.00	131.00	133.00	236.00	182.00	165.00
Inventory Days	483.00	286.00	331.00	430.00	434.00	503.00	312.00	310.00	381.00	321.00	276.00
Days Payable	150.00	135.00	150.00	190.00	185.00	152.00	201.00	112.00	210.00	129.00	108.00
Cash Conversion Cycle	492.00	310.00	306.00	357.00	368.00	456.00	242.00	331.00	407.00	374.00	334.00
Working Capital Days	231.00	193.00	166.00	153.00	163.00	177.00	159.00	177.00	275.00	209.00	195.00
ROCE %	17.00	28.00	28.00	26.00	21.00	32.00	25.00	25.00	—	37.00	—

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08	44.08
FIIs	7.53	7.79	7.58	8.03	9.10	9.35	8.33	8.10	7.11	6.49	7.00	7.30
DIIs	9.37	9.22	9.58	9.55	8.85	9.16	9.65	9.89	10.35	8.41	8.40	8.12
Public	39.04	38.90	38.75	38.32	37.94	37.41	37.93	37.95	38.46	41.03	40.52	40.50
No. of Shareholders	83,325	82,249	81,815	82,650	82,045	81,219	82,004	84,298	80,737	83,296	87,486	100,927

Corporate Actions

4 records

Action	Ex Date	Record Date	Ratio	Amount (₹)	Notes
Dividend	24 Jul 2026	24 Jul 2026	—	7.55
Dividend	03 Sep 2025	03 Sep 2025	—	10.70
Dividend	21 Jun 2024	22 Jun 2024	—	8.75
Other	21 Jun 2024	—	—	—	Annual General Meeting

Announcements

5 filings

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
21 Aug 2026 21 Aug - The officials of the Company will be attending an Investor Conference on 26th August 2026 as per the schedule and details in the file uploaded …
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
07 Aug 2026 7 Aug - Transcript of Q1 - FY27 Earnings call held on August 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
03 Aug 2026 3 Aug - Q1 FY27 earnings call recording hosted on company website after August 3, 2026 call.
Announcement under Regulation 30 (LODR)-Investor Presentation
01 Aug 2026 1 Aug - Investors'' Presentation on unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 1 Aug
01 Aug 2026